Evidence map›Paper›PMID 31619731›Full record

ArticleScientific reports2019

Alterations to the Gastrointestinal Microbiome Associated with Methamphetamine Use among Young Men who have Sex with Men.

Ryan R Cook, Jennifer A Fulcher, Nicole H Tobin, Fan Li, David J Lee, Cora Woodward, Marjan Javanbakht, Ron Brookmeyer, Steve Shoptaw, Robert Bolan and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. GutGut microbes · 2026
    Article
  5. Article
  6. Review
  7. Science signaling · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Overamped: Stimulant Use and HIV Pathogenesis.Current HIV/AIDS reports · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ryan R CookDepartment of Epidemiology, Fielding School of Public Health at the University of California, Los Angeles, USA. cookryan@ucla.edu.ORCID http://orcid.org/0000-0001-8754-995X
Jennifer A FulcherDivison of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, USA.
Nicole H TobinDivision of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at the University of California, Los Angeles, USA.
Fan LiDivision of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at the University of California, Los Angeles, USA.
David J LeeDivision of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at the University of California, Los Angeles, USA.
Cora WoodwardDivision of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at the University of California, Los Angeles, USA.
Marjan JavanbakhtDepartment of Epidemiology, Fielding School of Public Health at the University of California, Los Angeles, USA.
Ron BrookmeyerDepartment of Biostatistics, Fielding School of Public Health at the University of California, Los Angeles, USA.
Steve ShoptawDepartment of Family Medicine, David Geffen School of Medicine at the University of California, Los Angeles, USA.
Robert BolanLos Angeles LGBT Center, Los Angeles, USA.
Grace M AldrovandiDivision of Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at the University of California, Los Angeles, USA.
Pamina M GorbachDepartment of Epidemiology, Fielding School of Public Health at the University of California, Los Angeles, USA.
University of California, Los Angeles · USUniversity of Southern California · US

Funding

LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Jennifer Jao, Sharon A Nachman · 2011 to 2026
$278.1M
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGUM1AI068616 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Sean Scott Brummel, Marlene Ann Cooper · 2011 to 2026
$155.6M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
UCLA AIDS Prevention and Treatment Clinical Trials UnitUM1AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Judith S. Currier, RAPHAEL J LANDOVITZ · 2012 to 2026
$51.8M
LC - IMPAACT Leadership GroupUM1AI106716 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$47.2M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BALDWIN, GAYLE COCITA · 1991 to 2018
$39.9M
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) U01DA036267 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GORBACH, PAMINA MAE, SHOPTAW, STEVEN J · 2013 to 2024
$20.5M
UCLA AIDS Prevention and Treatment Clinical Trials UnitU01AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S. · 2007 to 2011
$13.9M
Microbiome and Mucosal Immune Interactions in the Pathogenesis of HIV-1 TransmissionK08AI124979 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FULCHER, JENNIFER · 2018 to 2021
$617k
The effects of HIV, substance use, and obesity on the gastrointestinal microbiome of young men of color who have sex with menR36DA046310 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI COOK, RYAN · 2018 to 2018
$53k
Doris Duke Charitable Foundation 2019086NIAID NIH HHS K08 AI124979NIAID NIH HHS P30 AI028697NIAID NIH HHS U01 AI069424NIAID NIH HHS UM1 AI068616NIAID NIH HHS UM1 AI068632NIAID NIH HHS UM1 AI069424NIAID NIH HHS UM1 AI106716NIDA NIH HHS R36 DA046310NIDA NIH HHS U01 DA036267NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

Methamphetamine (MA) use is a major public health problem in the United States, especially among people living with HIV (PLWH). Many MA-induced neurotoxic effects are mediated by inflammation and gut microbiota may play a role in this process, yet the effects of MA on the microbiome have not been adequately explored. Therefore, we performed 16S rRNA gene sequencing on rectal swab samples from 381 men who have sex with men, 48% of whom were PLWH and 41% of whom used MA. We compared microbiome composition between MA users and non-users while testing for potential interactions with HIV and controlling for numerous confounders using inverse probability of treatment weighting. We found that MA use explained significant variation in overall composition (R

Indexed as

BacteriaDrug UsersGastrointestinal MicrobiomeHomosexuality, MaleAdultHIV InfectionsHumansMaleMethamphetamineSexual and Gender MinoritiesYoung AdultMethamphetamine

Identifiers

PMID31619731
PMCPMC6795845
OpenAlexW2981306529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.